ArticleJournal of comparative effectiveness research2025
Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis.
Carrie M Hersh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.